Jefferies Financial Group Aktie News

STOCKHOLM, SE / ACCESS Newswire / November 17, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced participation in the Jefferies Global Healthcare Conference in London: Location : London, UK Format : Presentation and 1×1 meetings Presentation Date and Time : Tuesday, November 18 ...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Christophe Douat, Chief Executive Officer, and Dr. Richard Malamut, Chief Medical Officer, will present Medincell's (Paris:MEDCL) corporate overview during a fireside chat at the Jefferies London Global Healthcare Conference on Tuesday, November 18, 2025, at 4:00 p.m. GMT (5:00 p.m. CET). Live webcast and replay: https://wsw.com/webcast/jef...

DUBLIN , Nov. 12, 2025 /PRNewswire/ -- Keenova Therapeutics plc ("Keenova" or the "Company") today announced that management will present at the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025, at 10:00 a.m. Greenwich Mean Time (GMT) (5:00 a.m.

LONDON and CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics' or ‘the Company'), a leading clinical-stage biotechnology company with a mission to save and restore vision in people with rare and prevalent ocular diseases, today announced that members of its management team will participate in the Jefferies Global Healthcare Conference ...

AtaiBeckley NV (NASDAQ:ATAI, ETR:9VC) is gaining analyst attention after Phase 2b results for its investigational therapy BPL-003 demonstrated rapid, meaningful, and durable antidepressant effects in treatment-resistant depression (TRD), reinforcing its potential as a differentiated psychedelic therapy. Jefferies highlighted that the data could influence dosing strategies and commercial positio...

SYDNEY--(BUSINESS WIRE)-- #JefferiesGlobalHealthcareConference--AdvanCell to share positive 212Pb-ADVC001 results and US expansion updates at the Jefferies Global Healthcare Conference in London (17–20 Nov 2025).

LONDON--(BUSINESS WIRE)--Aqemia, a pioneering TechBio company combining generative AI and quantum-inspired physics to invent drugs, announces that Maximilien Levesque, CEO and co-founder, and Théa Vu-Bignand, VP Finance, will attend the Jefferies Global Healthcare Conference, taking place in London from November 17 – 20, 2025. With its physics-based generative AI platform for therapeutic molecu...

Apple Inc (NASDAQ:AAPL, ETR:APC)'s latest iPhone surge in China may be losing steam after an initial wave of strong demand for the iPhone 17 series, according to Jefferies analysts, who said sales are likely to taper as discounts and subsidies run out. Jefferies estimates that iPhone volumes in China grew about 40% year-over-year in October and 38% during the first 30 days of the Double 11 shop...